• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们如何衡量 Barrett 食管患者的健康相关生活质量?患者报告结局测量的系统评价。

How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurements.

机构信息

Department of Gastroenterology and Hepatology, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands.

Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Qual Life Res. 2022 Jun;31(6):1639-1656. doi: 10.1007/s11136-021-03009-7. Epub 2021 Nov 8.

DOI:10.1007/s11136-021-03009-7
PMID:34748137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9098608/
Abstract

PURPOSE

Barrett esophagus (BE) is associated with a significant decrease of health-related quality of life (HRQoL). Too often, patient-reported outcome measures (PROMs) are applied without considering what they measure and for which purposes they are suitable. With this systematic review, we provide researchers and physicians with an overview of all the instruments previously used for measuring HRQoL in BE patients and which PROMs are most appropriate from the patient's perspective.

METHODS

A comprehensive search was performed to identify all PROMs used for measuring HRQoL in BE patients, to identify factors influencing HRQoL according to BE patients, and to evaluate each PROM from a patients' perspective.

RESULTS

Among the 27 studies, a total of 32 different HRQoL instruments were identified. None of these instruments were designed or validated for use in BE patients. Four qualitative studies were identified exploring factors influencing HRQoL in the perceptions of BE patients. These factors included fear of cancer, anxiety, trust in physician, sense of control, uncertainty, worry, burden of endoscopy, knowledge and understanding, gastrointestinal symptoms, sleeping difficulties, diet and lifestyle, use of medication, and support of family and friends.

CONCLUSION

None of the quantitative studies measuring HRQoL in BE patients sufficiently reflected the perceptions of HRQoL in BE patients. Only gastrointestinal symptoms and anxiety were addressed in the majority of the studies. For the selection of PROMs, we encourage physicians and researchers measuring HRQoL to choose their PROMs from a patient perspective and not strictly based on health professionals' definitions of what is relevant.

摘要

目的

巴雷特食管(BE)与健康相关生活质量(HRQoL)显著下降有关。患者报告结局测量(PROM)经常被应用,但却没有考虑到它们所测量的内容以及适合的用途。通过本系统评价,我们为研究人员和医生提供了一份全面的综述,介绍了之前用于测量 BE 患者 HRQoL 的所有工具,以及从患者角度来看哪些 PROM 最合适。

方法

进行了全面的检索,以确定所有用于测量 BE 患者 HRQoL 的 PROM,确定影响 BE 患者 HRQoL 的因素,并从患者角度评估每个 PROM。

结果

在 27 项研究中,共确定了 32 种不同的 HRQoL 工具。这些工具都不是为 BE 患者设计或验证的。确定了四项定性研究,以探讨影响 BE 患者 HRQoL 的因素。这些因素包括对癌症的恐惧、焦虑、对医生的信任、控制感、不确定性、担忧、内镜检查负担、知识和理解、胃肠道症状、睡眠困难、饮食和生活方式、药物使用以及家人和朋友的支持。

结论

没有一项用于测量 BE 患者 HRQoL 的定量研究充分反映了 BE 患者对 HRQoL 的感知。只有胃肠道症状和焦虑在大多数研究中得到了关注。对于 PROM 的选择,我们鼓励测量 HRQoL 的医生和研究人员从患者的角度选择 PROM,而不仅仅是基于卫生专业人员对相关内容的定义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e161/9098608/1bfefe371625/11136_2021_3009_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e161/9098608/ed6766445c8b/11136_2021_3009_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e161/9098608/3c79ce3d475a/11136_2021_3009_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e161/9098608/a5cfa75adcd3/11136_2021_3009_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e161/9098608/1bfefe371625/11136_2021_3009_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e161/9098608/ed6766445c8b/11136_2021_3009_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e161/9098608/3c79ce3d475a/11136_2021_3009_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e161/9098608/a5cfa75adcd3/11136_2021_3009_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e161/9098608/1bfefe371625/11136_2021_3009_Fig4_HTML.jpg

相似文献

1
How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurements.我们如何衡量 Barrett 食管患者的健康相关生活质量?患者报告结局测量的系统评价。
Qual Life Res. 2022 Jun;31(6):1639-1656. doi: 10.1007/s11136-021-03009-7. Epub 2021 Nov 8.
2
Patient-reported outcome measures for assessing health-related quality of life in people with type 2 diabetes: A systematic review.患者报告结局测量在评估 2 型糖尿病患者健康相关生活质量中的应用:一项系统评价。
Rev Endocr Metab Disord. 2022 Oct;23(5):931-977. doi: 10.1007/s11154-022-09734-9. Epub 2022 Jul 2.
3
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
4
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
5
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
8
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.髋、膝或髋膝骨关节炎患者的运动干预和患者信念:一项混合方法综述
Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD010842. doi: 10.1002/14651858.CD010842.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

引用本文的文献

1
Development and validation of a novel Barrett's oesophagus patient reported outcome measure (B-PROM).一种新型巴雷特食管患者报告结局量表(B-PROM)的开发与验证
EClinicalMedicine. 2024 May 6;72:102606. doi: 10.1016/j.eclinm.2024.102606. eCollection 2024 Jun.
2
Mapping the literature on decision regret in patients with non-communicable diseases (NCDs): a scoping review protocol.绘制非传染性疾病(NCDs)患者决策后悔相关文献图谱:范围综述方案
BMJ Open. 2023 Jul 18;13(7):e072703. doi: 10.1136/bmjopen-2023-072703.
3
Quality of life measures in dysplastic Barrett's oesophagus are comparable to patients with non-dysplastic Barrett's oesophagus and do not improve after endoscopic therapy.

本文引用的文献

1
Factors influencing health-related quality of life in patients with Barrett's esophagus: a qualitative focus group study.影响 Barrett 食管患者健康相关生活质量的因素:一项定性焦点小组研究。
Eur J Gastroenterol Hepatol. 2022 Feb 1;34(2):161-167. doi: 10.1097/MEG.0000000000002070.
2
International guidance on the selection of patient-reported outcome measures in clinical trials: a review.国际临床试验中患者报告结局测量选择指南:综述。
Qual Life Res. 2021 Jan;30(1):21-40. doi: 10.1007/s11136-020-02625-z. Epub 2020 Sep 14.
3
Outcome after endoscopic treatment for dysplasia and superficial esophageal cancer - a cohort study.
发育不良性 Barrett 食管患者的生活质量指标与非发育不良性 Barrett 食管患者相当,且内镜治疗后不会改善。
BMJ Open Gastroenterol. 2023 Apr;10(1). doi: 10.1136/bmjgast-2022-001091.
4
Barrett Esophagus: Quality of life and factors associated with illness perception.巴雷特食管:生活质量和与疾病认知相关的因素。
United European Gastroenterol J. 2022 Sep;10(7):721-729. doi: 10.1002/ueg2.12266. Epub 2022 Jul 6.
Scand J Gastroenterol. 2020 Sep;55(9):1132-1138. doi: 10.1080/00365521.2020.1800813. Epub 2020 Aug 4.
4
Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett's Esophagus.内镜治疗与食管切除术治疗肿瘤性 Barrett 食管的长期生活质量比较。
Dig Dis Sci. 2021 May;66(5):1580-1587. doi: 10.1007/s10620-020-06377-1. Epub 2020 Jun 9.
5
Comparative quantitative survey of patient experience in Barrett's oesophagus and other gastrointestinal disorders.巴雷特食管和其他胃肠道疾病患者体验的比较定量调查。
BMJ Open Gastroenterol. 2020 Mar 31;7(1):e000357. doi: 10.1136/bmjgast-2019-000357. eCollection 2020.
6
Impact of ablation of Barrett's esophagus with low-grade dysplasia on patients' illness perception and quality of life: a multicenter randomized trial.低级别异型增生的 Barrett 食管消融对患者疾病认知和生活质量的影响:一项多中心随机试验。
Gastrointest Endosc. 2019 Aug;90(2):215-221. doi: 10.1016/j.gie.2019.04.226. Epub 2019 Apr 23.
7
Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer.与 Barrett 食管和癌症相关的健康相关生活质量。
World J Surg. 2019 Jun;43(6):1554-1562. doi: 10.1007/s00268-019-04936-w.
8
Barrett's oesophagus: A qualitative study of patient burden, care delivery experience and follow-up needs.巴雷特食管:患者负担、护理提供体验和随访需求的定性研究。
Health Expect. 2019 Feb;22(1):21-33. doi: 10.1111/hex.12817. Epub 2018 Nov 14.
9
Cancer risk perception in relation to associated symptoms in Barrett's patients: A cross sectional study on quality of life.巴雷特食管患者对癌症风险的认知与相关症状的关系:一项关于生活质量的横断面研究。
United European Gastroenterol J. 2018 Nov;6(9):1316-1322. doi: 10.1177/2050640618798508. Epub 2018 Sep 7.
10
Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here?巴雷特食管和早期食管癌的内镜治疗:我们将何去何从?
World J Gastrointest Endosc. 2018 Sep 16;10(9):165-174. doi: 10.4253/wjge.v10.i9.165.